Skip to content

Partnerships Built for Progress.

Specialized technologies. Shared expertise. More ways to advance your cell therapy program.

Cell therapy development depends on capabilities that span organizations and disciplines. Connecting them takes scientific expertise, operational planning, and a clear understanding of what your program needs next.

Made Scientific works with technology providers, therapy developers, and academic institutions to bring new tools into manufacturing, advance client programs, and develop the people behind GMP operations. Each partnership addresses a specific need, from starting materials and process automation to clinical supply and workforce training.

MadeDAPLabsJuly2025_025

Technology and supply partnerships

Technologies, materials, and equipment that expand what’s possible in cell therapy development and manufacturing.

RoosterBio logo

RoosterBio

MSC and extracellular vesicle platforms integrated into Made Scientific’s development and manufacturing services, from process development through commercial supply.

Read the announcement
Pluristyx logo

Pluristyx

Clinical-grade iPSC lines and derivative cell types paired with Made Scientific’s process development and manufacturing expertise to support progression toward the clinic.

Explore the partnership
Syenex logo

Syenex

RapidCell™ vector technology powers MadeFast™, Made Scientific’s single-step CAR-T platform designed to reduce manufacturing time, cost, and complexity.

Explore the partnership
Streamline Bio logo

Streamline Bio

Exclusive Early Adopter Program for the co-development, integration, and validation of AI-driven robotic automation for cell therapy manufacturing.

Explore the partnership
CARR Biosystems logo

CARR Biosystems

UniFuge® single-use centrifugation integrated across Made Scientific's Princeton and East Norriton facilities for scalable MSC manufacturing.

Explore the partnership
Telos Biotech logo

Telos Biotech

Evaluating TELOVANCE™, a telomerase-based technology, for potential use in CAR T-cell, NK-cell, and hematopoietic stem/progenitor cell workflows.

Read the announcement

Client programs and partnerships

Supporting therapy developers with the process development, manufacturing, and technical expertise their programs need to advance.

NurExone Biologic logo

NurExone Biologic

A binding MOU covering planned GMP manufacturing and aseptic fill-finish for NurExone’s bone marrow-derived exosomes.

Read the announcement
Columbia University logo

Columbia University

Process development and GMP manufacturing for NOVAKnee, a living biologic total knee replacement.

Read the announcement
Regenicin logo

Regenicin

Manufacturing and IND support for NovaDerm, an autologous skin substitute being developed for burns and wounds.

Read the announcement
Cytora Therapeutics logo

Cytora Therapeutics and Zeo ScientifiX

Exclusive U.S. manufacturing for Cytora's allogeneic oral mucosal stem cell therapy for diabetic foot ulcers, with Zeo ScientifiX as the exclusive U.S. commercial partner.

Read the announcement
Cellergy Therapeutics logo

Cellergy Therapeutics

Process scale-up and GMP production for CLG-001, an investigational mitochondrial transplantation therapy.

Read the announcement
Hemogenyx Pharmaceuticals logo

Hemogenyx Pharmaceuticals

Technology transfer and manufacturing for HG-CT-1, an autologous CAR-T therapy for acute myeloid leukemia.

Read the announcement
Sentinel BioTherapeutics logo

Sentinel BioTherapeutics

Cell banking and clinical manufacturing for SENT-001, an allogeneic encapsulated therapy for solid tumors.

Read the announcement

Academic and workforce partnerships

Working with academic institutions to connect education with the practical demands of cell therapy manufacturing.

New Jersey Institute of Technology logo

New Jersey Institute of Technology

Co-developed graduate electives that connect bioprocessing education with practical cell therapy manufacturing experience.

Read the announcement

Ways to partner

Card Icon

Dedicated Capacity and Embedded Teams

Align Made Scientific personnel and manufacturing capacity with your program’s requirements and schedule.

Best suited to programs that need continuity across development, analytical testing, and GMP manufacturing.

Card Icon

Hybrid Client-⁠in-⁠Plant

Run your program with your own staff inside Made Scientific’s GMP facilities through a hybrid client-in-plant model.

Best suited to mid- to late-stage programs that want their own team operating inside our facilities.

Card Icon

Technology and Supply Partnerships

Work with Made Scientific to evaluate and integrate technologies, materials, and equipment into cell therapy workflows.

Best suited to technology and supply partners seeking to establish how their solutions perform in development and GMP manufacturing settings.

Card Icon

Customized Build-⁠Outs

Plan fully customized build-outs for late-stage and commercial manufacturing, supported by GC’s long-term investment in capacity, technology, and experienced teams.

Best suited to late-stage and commercial programs aligning manufacturing with long-term strategic goals.

Why partner with Made Scientific

Planning for scale from the start

We consider manufacturing scale, analytical requirements, automation opportunities, and cost as processes develop, helping teams prepare for the demands of later-stage and commercial supply.

Partnerships shaped around your process

We assess technologies and workflows against your program’s technical requirements, regulatory considerations, and commercial objectives. Those needs guide how we structure the partnership.

Scientific expertise grounded in GMP execution

Our experience spans autologous and allogeneic cell therapies, including CAR-T, CAR-NK, TILs, MSCs, and iPSC-derived products. Development and manufacturing teams work together to connect process decisions with the requirements of GMP production.

Gowned operator loading samples into equipment in a Made Scientific GMP cleanroom
Made Scientific - Interactive Background

Let’s Build What Your Program Needs Next

Whether you’re advancing a therapy, developing a technology, or building manufacturing expertise, let’s explore where we can work together.